secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001438133-24-000158
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem and Dexcom amend agreements to integrate Sigi pump with G7 CGM for five years
--------------------------------------------------------------------------------

- On May 22, 2024, Tandem and Dexcom entered into two amended and restated agreements.
- The Development Agreement covers integration of Tandem's Sigi insulin pump with Dexcom's G7 CGM.
- Both agreements extend the term to five years and amend definitions and commercial terms.
- The Commercialization Agreement addresses the sale and support of the integrated systems.
- Original agreements were signed November 2020; new deals update device scope and conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000158/0001438133-24-000158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000158/tndm-20240522.htm
  HTML page:      https://secwatch.observer/filing/0001438133-24-000158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer